Scores of participants in South Africa’s first clinical trial for a vaccine against COVID-19 have been vaccinated. The first clinical trial in South Africa and on the continent for a COVID-19 vaccine was announced on 23 June, at a virtual press conference hosted by the University of the Witwatersrand, Johannesburg (Wits). Wits University is collaborating with the University of Oxford and the Oxford Vaccine Group on the South African trial. The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus…
Read More